CCN5 mitigates myosteatosis and counteracts sarcopenia by promoting mitochondrial biogenesis and enhancing LD-Mt interactions through dual pathways, positioning it as a promising therapeutic target for muscle aging and sarcopenia.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zile Shen
Zhang Liu
Guowei Huang
Journal of Cachexia Sarcopenia and Muscle
Tongji University
Wenzhou Medical University
Shanghai Tenth People's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Shen et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d8946e6c1944d70ce0553e — DOI: https://doi.org/10.1002/jcsm.70282